MedPath

Ceftaroline Diffusion Into Cerebrospinal Fluid of Children

Phase 1
Conditions
Cerebrospinal Fluid Shunts
Ventriculoperitoneal Shunt
Interventions
Registration Number
NCT02600793
Lead Sponsor
Basim Asmar
Brief Summary

Ceftaroline fosamil is an intravenous (IV) drug that belongs to a group of antibiotics called cephalosporins . Antibiotics are drugs used to treat infections. Clinical studies in adults patient shave shown ceftaroline fosamil to be effective against many bacteria that are resistant to other currently approved antibiotics. Some of these bacteria may be responsible for infections in the central nervous system.The main aim of this study is to gather information to determine how much of a single IV dose of ceftaroline fosamil will enter into a child's CSF so that the benefit of giving ceftaroline fosamil to children with infections can be better determined.

Detailed Description

Children 6 months to 17 years of age admitted to the hospital because of infected VPS (ventriculitis) will be eligible for the study. A total of twelve eligible patients will be included in the study. Eligible study subjects would be patients who have undergone VPS removal and placement of EVD tubing and are being treated with standard IV antibiotics for ventriculitis. CSF cultures are obtained before antibiotics treatment is initiated. Standard initial antibiotics regimen is usually IV ceftriaxone and vancomycin. The antibiotics regimen is subsequently adjusted based on the pathogen recovered from the CSF culture. Total IV antibiotic treatment is usually 14 days. Following clearance of the infection the patient undergoes new VPS insertion by neurosurgery service.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Age 6 months - 17 years
  • Ventriculitis due to VPS infection (abnormal CSF parameters consistent with meningeal inflammation and/or positive CSF culture)
  • VPS is externalized and External Ventriculostomy Drain (EVD) is in place
  • Patient has IV access and is receiving antibiotic treatment for VPS infection
  • Parent/Guardian signed written informed consent
  • Negative urine or serum pregnancy test for females of child-bearing potential
Exclusion Criteria
  • Known Allergy to beta-lactam antibiotics
  • Moderate to severe renal impairment (Creatinine clearance < 50mL/minute)
  • Parent/Guardian written consent cannot be obtained
  • Positive urine or serum pregnancy test

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Arm 1CeftarolineSingle dose IV ceftaroline will be administered
Primary Outcome Measures
NameTimeMethod
Pharmacokinetic assessment of Ceftaroline diffusion from blood into the Cerbrospinal fluid.8 hours

Serial collection of three blood and three cerbrospinal fluid sample over 8 hours

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's Hospital of Michigan

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath